Heterogeneity of national legislation and practice on clinical trials with vulnerable patients based on the EU Clinical Trials Directive by the example of adults permanently incapable of giving informed consent
In principle, persons wishing to participate in a clinical trial must give informed consent in advance after comprehensive information has been provided. Under certain conditions, it is possible to deviate from this requirement in the European Union (EU) in order to enable the participation of so-ca...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | deu |
Published: |
German Medical Science GMS Publishing House
2021-03-01
|
Series: | GMS German Medical Science |
Subjects: | |
Online Access: | http://www.egms.de/static/en/journals/gms/2021-19/000290.shtml |